Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients

PURPOSE: There is growing interest in the application of circulating tumour DNA (ctDNA) as a sensitive tool for monitoring tumour evolution and guiding targeted therapy in patients with cancer. However, robust comparisons of different platform technologies are still required. Here we compared the In...

Descripción completa

Detalles Bibliográficos
Autores principales: Nteliopoulos, Georgios, Page, Karen, Hills, Allison, Howarth, Karen, Emmett, Warren, Green, Emma, Martinson, Luke J., Fernadez-Garcia, Daniel, Hastings, Robert, Guttery, David S., Kenny, Laura, Stebbing, Justin, Cleator, Susan, Rehman, Farah, Gleason, Kelly L. T., Sanela, Andrijac, Ion, Charlotte, Rushton, Amelia J., Rosenfeld, Nitzan, Coombes, R. Charles, Shaw, Jacqueline A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260509/
https://www.ncbi.nlm.nih.gov/pubmed/34097174
http://dx.doi.org/10.1007/s10549-021-06220-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260509/
https://www.ncbi.nlm.nih.gov/pubmed/34097174
http://dx.doi.org/10.1007/s10549-021-06220-9

Ejemplares similares